Cargando…

How can proton pump inhibitors damage central and peripheral nervous systems?

Detalles Bibliográficos
Autores principales:	Makunts, Tigran, Abagyan, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716020/ https://www.ncbi.nlm.nih.gov/pubmed/32394957 http://dx.doi.org/10.4103/1673-5374.282252

Ejemplares similares

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
por: Makunts, Tigran, et al.
Publicado: (2019)

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
por: Makunts, Tigran, et al.
Publicado: (2019)

Common osteoporosis drug associated with increased rates of depression and anxiety
por: Keshishi, Dro, et al.
Publicado: (2021)

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
por: Joulfayan, Haroutyun, et al.
Publicado: (2023)

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
por: Makunts, Tigran, et al.
Publicado: (2020)

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
por: Makunts, Tigran, et al.
Publicado: (2019)

Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events
por: Makunts, Tigran, et al.
Publicado: (2022)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
por: Makunts, Tigran, et al.
Publicado: (2023)

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Cohen, Isaac V., et al.
Publicado: (2021)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain
por: Makunts, Tigran, et al.
Publicado: (2018)

How do corticosteroids influence myelin genesis in the central nervous system?
por: Chari, Divya M.
Publicado: (2014)

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
por: Wollmer, M. Axel, et al.
Publicado: (2021)

Axotomy induces damage to glial cells remote from the transection site in the peripheral nervous system
por: Uzdensky, Anatoly B.
Publicado: (2018)

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
por: Cohen, Isaac V., et al.
Publicado: (2020)

Delayed peripheral treatment with neurotrophin-3 improves sensorimotor recovery after central nervous system injury
por: Kakanos, Sotiris G., et al.
Publicado: (2019)

Vascular inflammation in the central nervous system
por: Guo, Xinying, et al.
Publicado: (2022)

Quo vadis? Bioengineered polysaccharide-based hydrogel scaffolds for damaged central nervous system recovery and regeneration
por: Carvalho, Isadora C., et al.
Publicado: (2021)

How does chronic dry eye shape peripheral and central nociceptive systems?
por: Guerrero-Moreno, Adrian, et al.
Publicado: (2020)

How chemotherapy damages the central nervous system
por: Meyers, Christina A
Publicado: (2008)

Central Nervous System Histoplasmosis: An Updated Insight
por: Ramírez, José Antonio, et al.
Publicado: (2023)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Chronic oligodendrocyte injury in central nervous system pathologies
por: Molina-Gonzalez, Irene, et al.
Publicado: (2022)

Microtubule dynamics in the peripheral nervous system: A matter of balance
por: Almeida-Souza, Leonardo, et al.
Publicado: (2011)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

Impact of gut-peripheral nervous system axis on the development of diabetic neuropathy
por: Mázala-de-Oliveira, Thalita, et al.
Publicado: (2023)

Self-healing hydrogel for tissue repair in the central nervous system
por: Hsieh, Fu-Yu, et al.
Publicado: (2015)

Neuroprotective role of galectin-1 in central nervous system pathophysiology
por: Aalinkeel, Ravikumar, et al.
Publicado: (2016)

Collagen 1 signaling at the central nervous system injury site and astrogliosis
por: Neo, Sin Hui, et al.
Publicado: (2017)

CXCR4 signaling in central nervous system regeneration: friend or foe?
por: Terheyden-Keighley, Daniel, et al.
Publicado: (2021)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Axon guidance in regeneration of the mature central nervous system: step by step
por: Schaeffer, Julia, et al.
Publicado: (2023)

Glyphosate-based herbicide: a risk factor for demyelinating conditions of the peripheral nervous system?
por: Szepanowski, Fabian, et al.
Publicado: (2019)

The necessary role of mTORC1 in central nervous system axon regeneration
por: Hu, Yang
Publicado: (2015)

The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015)

Role of granulocyte macrophage colony stimulating factor in regeneration of the central nervous system
por: Shanmugalingam, Ushananthini, et al.
Publicado: (2016)

Sox9 in the developing central nervous system: a jack of all trades?
por: Vogel, Julia K., et al.
Publicado: (2020)

Putting PLX5622 into perspective: microglia in central nervous system viral infection
por: Spiteri, Alanna G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8g26jg0hb5oa4s94omai9n3nu0